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Monosomy 1p36 is the most common subtelomeric chromosomal deletion linked to mental retardation and
seizures. Neuroimaging studies suggest that monosomy 1p36 is associated with brain malformations including
polymicrogyria and nodular heterotopia, but the histopathology of these lesions is unknown. Here we present
postmortem neuropathological findings from a 10 year-old girl with monosomy 1p36, who died of respiratory
complications. The findings included micrencephaly, periventricular nodular heterotopia in occipitotemporal lobes,
cortical dysgenesis resembling polymicrogyria in dorsolateral frontal lobes, hippocampal malrotation, callosal
hypoplasia, superiorly rotated cerebellum with small vermis, and lumbosacral hydromyelia. The abnormal cortex
exhibited “festooned” (undulating) supragranular layers, but no significant fusion of the molecular layer. Deletion
mapping demonstrated single copy loss of a contiguous 1p36 terminal region encompassing many important
neurodevelopmental genes, among them four HES genes implicated in regulating neural stem cell differentiation,
and TP73, a monoallelically expressed gene. Our results suggest that brain and spinal malformations in monosomy
1p36 may be more extensive than previously recognized, and may depend on the parental origin of deleted genes.
More broadly, our results suggest that specific genetic disorders may cause distinct forms of cortical dysgenesis.
Keywords: Periventricular nodular heterotopia, Hippocampal malrotation, Cortical dysgenesis, Malformations of
cortical development, Hydromyelia, Mental retardation, EpilepsyBackground
Monosomy 1p36 is the most common subtelomeric
chromosomal deletion syndrome, with an estimated in-
cidence of 1/5000-1/10000 births [1]. Of the ~95% of
deletions that arise de novo, 60% affect the maternally
derived chromosome [1], and manifest as various kinds of
chromosomal rearrangements (e.g., interstitial deletions, de-
rivative chromosomes, and more complex rearrangements,
as well as pure terminal deletions). The clinical phenotype
of monosomy 1p36 includes mental retardation, develop-
mental delay, muscular hypotonia, speech delay, epilepsy,
behavioral disorders (including panic, aggressiveness,
and self-injury), sensorineural hearing loss, eye/vision
problems, congenital heart defects, cardiomyopathy,
gastrointestinal problems, precocious puberty, hyperphagia/
obesity, and dysmorphic features (deep-set eyes, flat nasal* Correspondence: rhevner@uw.edu
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reproduction in any medium, provided the orbridge, pointed chin, large and late-closing anterior fonta-
nel, and clinodactyly) [1-5]. Mental retardation and devel-
opmental delay are seen in nearly 100% of patients, and are
usually moderate or severe [5,6]. Generalized hypotonia is
observed in >90% of patients, and epilepsy in 50-80% [4,6].
The chromosome deletion in most cases maps to the
distal 10.5 Mb of 1p36, although the size varies and there
is no common break point [1]. There is little correlation
between the deletion size and the number of clinical fea-
tures; even relatively small deletions (<3 Mb) can present
with most of the typical phenotypic features [3,7]. Indeed,
it has been suggested that some features of monosomy
1p36 might result from positional effects rather than a
simple contiguous gene deletion [8]. On the other hand,
the severity of neurological deficits including epilepsy,
mental retardation and sensorineural hearing loss, as well
as congenital heart diseases, has been suggested to correl-
ate with the deletion size [6,8]. Furthermore, some specific
phenotypes in the monosomy 1p36 syndrome — including
polymicrogyria (PMG), hyperphagia/obesity, mental retard-
ation, seizures, hearing loss, and periventricular nodulartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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within 1p36, each of which nevertheless contains multiple
genes [2,4,9-11].
Although neuropsychiatric abnormalities are pivotal
phenotypes in monosomy 1p36, their pathogenesis remains
poorly understood. In most cases, neuroimaging reveals
only mild or nonspecific changes such as microcephaly,
ventriculomegaly, cerebral atrophy, abnormal patchy signal
in white matter, and delayed myelination. Recently,
however, evidence has accumulated that some fraction
of monosomy 1p36 cases are affected with significant
developmental brain malformations, including PMG,
PNH, hypoplasia or agenesis of the corpus callosum,
holoprosencephaly, cerebellar hypoplasia, and choroid
plexus hyperplasia [10,12-19]. In one series, for example,
13 of 64 (20.3%) patients with monosomy 1p36 showed
neuroimaging evidence of PMG [10].
In the present case report, we present the first neuro-
pathological analysis of brain and spinal cord malformations
in monosomy 1p36, from postmortem examination of a girl
who died at 10 years of age. Our findings reveal new details
of the malformations, and suggest that PMG in these
patients represents a distinct form of cortical dysgenesis.
Case presentation
Clinical history
The subject was delivered at 39 weeks of gestation by
caesarean section for breech position, to a 22 year-old,
gravida 2, para 1 (1 spontaneous abortion) mother who had
received special education in school. The father was a
nonconsanguineous 37 year-old man with no known
medical problems or significant family history. Birth weight
was 2035 g (−3.7 SD). Apgar scores were 7 at 1 minute and
8 at 5 minutes. Neonatal cardiac evaluation showed a
patent ductus arteriosus (PDA) and small ventricular septal
defect (VSD). The PDA was ligated at age 7 weeks and the
VSD closed spontaneously. She had severe conjugated
hyperbilirubinemia transiently during early infancy, along
with other findings suggestive of possible Alagille syndrome
(posterior embryotoxon and butterfly vertebrae). However,
liver biopsy showed no paucity of bile ducts (as present in
Alagille syndrome) nor any other disease specific finding.
Postnatal growth retardation (height < 5th centile), micro-
cephaly (head circumstance < 5th centile), feeding difficul-
ties, muscular hypotonia, and delayed motor and mental
development were also noted. Infantile apneic spells were
noted, prompting magnetic resonance imaging (MRI) that
revealed cervicomedullary compression at the skull base;
this was surgically decompressed. At 8 months of age, the
patient was referred to the Department of Medical Genetics
and was noted to exhibit dysmorphic features including bi-
lateral low set small malformed ears, prominent forehead,
deep set eyes, flat nasal bridge, pointed chin, short neck,
and bilateral single transverse creases.At age 13 months, growth hormone deficiency of un-
known etiology was diagnosed and treated with growth
hormone replacement therapy. The patient had severe
gastro-esophageal reflux causing recurrent aspiration
pneumonia; Nissen fundoplication with gastrostomy was
done at 15 months of age. Precocious secondary sexual
characteristics and clitoromegaly were noted at 22 months.
The first apparent generalized tonic-clonic seizure occurred
at age 5 years; seizures progressed, and were ultimately
treated with combination anti-epileptic drug therapy. On
serial neurological examinations, the patient never spoke
any words nor walked, and her development remained pro-
foundly delayed. She also had myopia with astigmatism and
sensorineural hearing loss bilaterally. Self-injurious behavior
(arm chewing) and teeth grinding were observed.
G-band karyotyping of peripheral blood lymphocytes
showed a terminal deletion of chromosome 1p, read as
46,XX,del(1)(p36.31). The deletion in this region was con-
firmed by fluorescence in situ hybridization (FISH) using
a subtelomeric DNA probe specific for the region, 1p36.3
(D1Z2; Oncor, Inc., cat #p5000-DG). The mother’s karyo-
type was normal; the father’s karyotype was not available.
MRI examinations of the brain at several ages disclosed
bilateral ventriculomegaly (Figure 1A-D). No progression
of ventriculomegaly was noted upon repeated brain
MRI. Electroencephalogram recordings showed slow
background activity and frequent high amplitude multifocal
discharges from the bilateral occipital lobes, compatible
with focal epilepsy.
The patient died at age 10 years from cardiorespira-
tory failure.
General autopsy findings
A complete autopsy was performed with familial consent.
The postmortem interval was 23.5 hours. The lungs showed
patchy severe pneumonia, with postmortem lung cultures
positive for Pseudomonas aeruginosa. The heart showed
dysplasia of atrioventricular valves, but no cardiomyopathy.
No hepatic or renal abnormalities were present.
Materials and methods
Neuropathological analysis
The brain was removed within 48 hours after death and
was fixed for two weeks in 10% formalin. Representative
samples of formalin-fixed brain and spinal cord were
embedded in paraffin, sectioned at 6 μm, and mounted
on glass slides. Hematoxylin and eosin (H-E), Luxol fast
blue (LFB), and cresyl violet (Nissl) stains utilized standard
protocols. Age-matched normal human brain specimens
were studied as controls.
Single-label immunoperoxidase staining was done using
standard procedures. Double-label immunofluorescence
was done as described [20]. The following primary anti-
bodies were used: rabbit polyclonal antibodies against
Figure 1 MRI images at ages 1 and 10 years. (A) Sagittal T2
weighted image at age 1 year showed a small cerebellar vermis
(black arrows) and abnormal posterior arch of C1 (white arrow)
causing compression of the posterior aspect of the upper cervical
spinal cord. (B) Parasagittal T1 weighted image at age 10 years
showed subtle irregularity of the cortical-white matter junction and
the surface of the cortex in the left frontal lobe (arrows), consistent
with polymicrogyria or similar dysgenesis. (C) Coronal T2 weighted
image at age 10 years showed ventriculomegaly and malrotated
hippocampi. (D) Coronal T2 weighted image at age 10 years at the
level of the ventricular trigones showed periventricular nodular
heterotopia of moderate (black arrow) and small (white arrow) sizes.
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monoclonal antibodies against neurofilament heavy chain
(clone N52; Chemicon, Temecula, CA; diluted 1:300);
microtubule-associated protein 1B (MAP1B; Chemicon;
1:400), microtubule-associated protein 2 (MAP2; Chemicon;
1:500), synaptophysin (Chemicon; 1:400), rabbit poly-
clonal antibodies against calretinin (CR; Swant, Bellinzona,
Switzerland; 1:2000). Primary antibody specificity was veri-
fied in control cortex. As a control for nonspecific binding
of secondary antibodies, primary antibodies were omitted
from some incubations.
Brightfield and fluorescence images were acquired
using a Carl Zeiss Axio Imager Z1 microscope equipped
with motorized stage and MosaiX software (Zeiss, USA).
Images were photographed digitally and processed using
Photoshop (Adobe, San Jose, CA, USA) to optimize bright-
ness, contrast, and resolution. To map the positions of
cells associated with deep and superficial cortical layers,
N52+ cells and CR + cells (respectively) were plotted using
different color dots (N52+ cells green, CR + cells red)
against a black background, as described [21].High-resolution chromosomal deletion mapping
Chromosomal deletions and duplications were analyzed
using a bacterial artificial chromosome (BAC)-based micro-
array (SignatureChip v3.0, Signature Genomic Laboratories,




The brain was small for age, weighing 858 g after forma-
lin fixation, much less than expected (1290 g). The most
prominent external brain abnormality was the “Moroc-
can leather”-like appearance of gyri in the dorsolateral
frontal lobes bilaterally (Figure 2A-C). The gyral surface
abnormalities, while most severe in the posterior portions
of middle and superior frontal gyri, were not sharply
delimited, but extended into adjacent cortical regions with
gradually decreasing severity. Coronal slices of the hemi-
spheres revealed bilateral ventriculomegaly, thin corpus
callosum, focal cortical thickening especially in frontal
lobes, and overall paucity of white matter (Figure 2D, E).
Measurements of (non-polymicrogyric) cortex at several
sulcal fundi showed the thickness ranged from 4.5 -7.6 mm,
whereas normal cortex has a thickness of 3-4 mm [23]. Mul-
tiple periventricular heterotopias were identified, exhibiting
both thin laminar and discrete nodular morphologies,
scattered in the walls of the ventricular atria as well as
occipital and temporal horns bilaterally (Figure 2E, E’).
The macroscopic PNH measured ~0.3–1.0 cm in greatest
dimension. The hippocampi were malrotated bilaterally
(see below). The cerebellum exhibited a displaced, small,
and anteriorly rotated vermis with normal organization
of lobules (Figure 2F-H). The central canal of the lower
thoracic and upper lumbar cord was mildly dilated
(hydromyelia) (Figure 2I).
Histopathology of PMG-like cortical dysgenesis
Routine histological stains (H-E, LFB, Nissl) demon-
strated six-layered cortex with possible “festooning” of
the supragranular layers, but little or no significant
fusion of the molecular layer. Rather, the molecular layer
appeared to have variable thickness and irregular con-
tours. To further analyze the PMG-like cortex, we used
immunohistochemistry to study layer-specific antigens
[24], including: N52 (neurofilament heavy chains, phos-
phorylated and non-phosphorylated), labeling pyramidal
neurons in layers 5 and 3; MAP1B, labeling deep more
intensely than in superficial layers; and CR, labeling in-
terneurons in layers 2–3 [24]. These studies revealed
additional details of festooning and variable thickness in
supragranular layers (Figure 3A-K). First, it was clear
that macroscopic PMG-like bumps on the cortical sur-
face (Figure 2C) correlated with thickening or convex
undulations of the supragranular layers, while tiny sulci
Figure 2 Macroscopic neuropathology. (A) Superior aspect of brain showed “Moroccan leather” appearance of frontal cortex bilaterally.
(B) Inferior aspect of brain showed smooth gyral surfaces. (C) Surface of right frontal cortex corresponding to boxed area in (A), with
leptomeninges removed, showed irregular surface of cortical gyri. (D) Coronal slice through the hemispheres revealed bilateral polymicrogyria-like
cortical dysgenesis (arrows) involving superior and middle frontal gyri. The gray-white matter junction was irregular in these regions. The corpus
callosum was thin, and the lateral and third ventricles were enlarged. (E) Coronal slices of the left occipital lobe demonstrated multiple
periventricular nodular heterotopia (arrows). (E’) Magnified view of boxed area in E with multiple heterotopia (arrows). (F-H) The cerebellum
exhibited a small, anteriorly rotated vermis with normal number of lobules. (I) Central canal of the lower thoracic and upper lumbar cord was
mildly dilated. Scale bars: (in A) A, B, 3 cm; C, 1 cm; D, 3 cm; E, 2 cm; E’, 1 cm; (in F) F, G, 3 cm; H, 2 cm; I, 0.5 cm.
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dulations. Furthermore, the immunostains revealed that
PMG-like cortical dysgenesis was more widespread than
appreciated from abnormal surface morphology. For
example, foci of supragranular festooning were evident
not only in dorsolateral regions, but also in medial frontal
and cingulate cortex, especially at the depths of sulci
(Figure 3A, B). Nevertheless, the relative positions of
supragranular and infragranular layers were preserved, as
revealed by double labeling to detect CR (layers 2–3) and
N52 (layers 5 and 3) in the same sections (Figure 3H-K).
The cerebral white matter was atrophic, gliotic, and
hypomyelinated (not shown).
Histopathology of periventricular heterotopia
The neuronal identity of PNH and adjacent thin laminar
heterotopia along the walls of the occipital and temporal
horns was confirmed by immunohistochemistry to detectsynaptophysin (Figure 3L). In addition, many numerous
smaller nodular or linear heterotopia (<3 mm), often aligned
along the interface between the subventricular zone
and white matter, were synaptophysin immunoreactive
(Figure 3L). These findings indicated that heterotopia, like
regions of cortical dysgenesis, were more extensive than
appreciated from macroscopic examination. Also, the PNH
contained multiple neuron types, including N52+ pyr-
amidal neurons as well as CR + interneurons (Figure 3M).
Interestingly, in some PNHs, N52+ neurons were located
predominantly in the center of the nodule, and CR + inter-
neurons around the outside (Figure 3M, nodule at right).
This observation suggests that some nodules may have had
a rudimentary laminar structure.
Histopathology of the brainstem, cerebellum, and spinal cord
The inferior olivary nuclei appeared mildly hypoconvoluted
(Figure 3N). The cerebellar cortex exhibited patchy loss of
Figure 3 Histologic neuropathology. (A, B) Polymicrogyria-like cortical dysgenesis stained by immunohistochemistry for (A) N52 and (B)
MAP1B. Note “festooned” supragranular layers in the patient’s superior frontal gyrus (SFG) and adjacent dorsolateral frontal cortex (superior up,
lateral left). The cingulate cortex (Cg) was unaffected, except in the depth of the cingulate sulcus. The corpus callosum (CC) was hypoplastic.
(C-E) Lamination of normal, age-matched control cortex demonstrated by (C) N52, (D) MAP1B, and (E) cresyl violet (Nissl) stains. (F, G)
Polymicrogyria -like cortical dysgenesis seen at higher magnification (boxed areas from A, B). (H-K) Two-color, double-label immunofluorescence
detection of N52 (green) and calretinin (red) in control (H, J) and patient (I, K) cerebral cortex. Low magnification views (H, I) show dot plots
of immunolabeled cells. In patient cortex, the number and size of N52+ neurons appeared smaller, but the relative positions of N52+ and
calretinin + neurons were unaltered. (L) Multiple synaptophysin-immunoreactive periventricular nodular heterotopia and small irregular
heterotopia were identified in occipitotemporal regions adjacent to the lateral ventricle (LV). (M) Periventricular heterotopia exhibited N52
(green) and calretinin (red) immunoreactivity, represented in dot plots. Insets (a, b) show higher magnification photomicrographs. (N) The inferior
olivary nuclei appeared slightly simplified with reduced convolutions. (O) The central canal of the spinal cord showed mild hydromyelia with a
cross-shaped dilatation in lower thoracic and upper lumbar levels. Note also pallor of anterior and lateral funiculi. Scale bars: (in A) A, B, 5 mm;
(in C) C-E, 1 mm; (in F) F, G, 1 mm; (in H) H, I, 500 μm; (in J) J, K, 250 μm; L, 2 mm; M, 500 μm; N, 2 mm; O, 2 mm.
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The spinal central canal was moderately dilated at lower
thoracic and upper lumbar levels (Figure 3O).Histopathology of the hippocampus
The bilateral hippocampi were malrotated through 90
degrees as viewed in a coronal plane (Figure 4). Major
Figure 4 Hippocampal malrotation. (A, C) Normal control hippocampus (stained with Luxol fast blue, and hematoxylin and eosin) and
interpretive line diagram. (B, D) Patient hippocampus (immunostained to detect MAP2) and diagram. (B’) Higher magnification of patient’s
dentate gyrus showing reduced neuronal population. The patient’s hippocampus, including dentate gyrus (D), CA1-CA3, and subiculum (S) was
rotated by ~90 degrees from normal orientation. The temporal horn (T) of the lateral ventricle directly contacted the subiculum in patient but
not control brain. The entorhinal cortex (EC), characterized by large neuron clusters in supragranular layers, appeared expanded in the patient
brain (small arrows in D). Other abbreviations: P, presubiculum; L, lateral geniculate nucleus; PNH, periventricular nodular heterotopia; TEC,
transentorhinal cortex. Large arrows indicate collateral sulcus. Scale bars: (in B) A-D, 750 μm; B’, 75 μm.
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and subiculum) were normally differentiated, but were
oriented vertically rather than horizontally as in a normal
control brain (Figure 4). The patient’s subiculum was
not attached to subjacent white matter, but instead was
in direct contact with the expanded lateral ventricle,
suggesting persistence of the fetal ventricular anatomy
(Figure 4B, D). This configuration contrasted with the
normal age-matched control hippocampus, in which
the subiculum contacts subjacent white matter contiguous
to the entorhinal cortex (Figure 4A, C). The entire
hippocampus was also atrophic and gliotic, with marked
neuronal loss in all regions, including the dentate gyrus
(Figure 4B’). Interestingly, the entorhinal cortex appeared
possibly expanded, and the choroid plexus appeared
relatively large (Figure 4B), although no systematic chor-
oid plexus hyperplasia was noted on MRI or macroscopic
brain examination.
Chromosomal deletion mapping and affected genes
To gain further insights into the pathogenesis of brain and
spinal malformations, we wished to map the chromosomal
deletion with better resolution than provided by the clinicalkaryotype. Microarray analysis using 969 BAC clones cov-
ering 304 genetic loci on 41 chromosome arms disclosed
single copy loss of DNA from 34 BAC clones, covering
a contiguous segment of 1p36 from Rp11-54O7 to RP1-
126A5 (Figure 5). This deletion included approximately
6.8 Mb of distal chromosome 1p, within the typical range
of deletion sizes for this syndrome [1,3]. The deleted seg-
ment contains 112 known or predicted genes, including
CAMTA1, which is located within the identified breakpoint
region and may have been partially deleted (Figure 5, and
Additional file 1) [25]. Many of the deleted genes have
previously been implicated in nervous system development
by studies in humans and mice (Table 1). For example, Hes
genes are known to be critical for brain and spinal growth
in mice [26,27], and four HES genes (HES2, HES3, HES4,
HES5) were deleted in the present case. The potential roles
of deleted genes in causing brain and spinal malformations
in monosomy 1p36 will be discussed further below.
Discussion
The current monosomy 1p36 case, with a 6.8 Mb
subtelomeric deletion, presented with conspicuous neuro-
psychiatric abnormalities and other typical clinical
Figure 5 Terminal deletion in the distal short arm of chromosome 1. Microarray analysis showed a single-copy loss of 34 BAC clones from
1p36.3, spanning approximately 6.8 Mb, with break point between RP1-126A5 and RP3-438 L4. Probes are arranged with the most distal p-arm
clones on the left. The blue tracing shows array comparative genomic hybridization data from the first microarray slide (reference Cy5/patient Cy3).
The pink tracing shows data from the second microarray slide in which the dyes have been reversed (patient Cy5/reference Cy3). A subset of genes
involved in neural development or function are indicated at their approximate position in the deleted region.
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also had some disorders that are not typically associ-
ated with monosomy 1p36, namely transient conju-
gated hyperbilirubinemia in early infancy, and growth
hormone deficiency. Postmortem neuropathological exam-
ination revealed significant brain and spinal malformations,
including: (1) occipitotemporal PNHs; (2) bifrontal cortical
dysgenesis resembling PMG; (3) callosal hypoplasia; (4)
hippocampal malrotation; (5) small, anteriorly rotated
vermis; (6) simplified inferior olives; and (7) hydromyelia in
the lower thoracic and upper lumbar spinal cord. However,
the hydromyelia was mild, and may have been secondary to
cervicomedullary compression. None of the malformations
were detected during life, and the last four have not previ-
ously been reported in monosomy 1p36. Thus, our findings
suggest that brain and spinal malformations in monosomy
1p36 may have been underestimated in previous studies.
The present study may help to raise awareness and increase
detection of these malformations in monosomy 1p36 [51].
Polymicrogyria-like cortical dysgenesis in monosomy 1p36
PMG is a poorly understood malformation characterized
by excessive small gyri (often lending the cortex an irregular
“Moroccan leather” surface appearance) and fusion of
the molecular layer [52]. The first report of “possible
polymicrogyria” in monosomy 1p36 was published in 1999[14]. The presumed PMG in that case involved the left
hemisphere, but no brain imaging or neuropathology was
shown. More recently, it was reported that 13 of 64 (20%)
monosomy 1p36 patients showed MRI evidence of PMG
[10]. Interestingly, the apparent PMG affected perisylvian
cortex preferentially, and involved the right hemisphere
more often than the left. Also, the smallest deletion in that
series was the last 4.8 Mb of 1p36, implying a critical region
between BAC RP5-1096P7 and the 1p telomere. Subsequent
studies have reported perisylvian PMG in three additional
monosomy 1p36 patients [13,18,19]. Pachygyria and “coarse
and nodular” cortex have also been described by neuroimag-
ing in monosomy 1p36 [12]. However, none of the previous
reports have documented the macroscopic brain pathology,
or the histopathology of PMG in monosomy 1p36. Thus,
the accuracy of the PMG diagnosis in monosomy 1p36, and
its relation to other forms of PMG (not associated with
monosomy 1p36), have remained uncertain.
Neuropathologists have distinguished several histological
types of PMG on the basis of laminar morphology, but
the significance of these variations is uncertain. The
most common types of PMG have been described as
“unlayered” and “four-layered”; less frequently, “two-
layered” and “six-layered” PMG have been described
[52-54]. In the present case, the cortical dysgenesis
most resembled “six-layered” PMG. However, different
Table 1 Genes related to development and function of nervous system within region of 1p36.21-1p36.33 deletion
Symbol Description Locus Site Mouse
ortholog
Human diseases Null mouse phenotype Other Refs.
KLHL17 kelch-like 17 (Drosophila) 1p36.33 885,830..890,958 Klhl17 postsynaptic membrane [28]
HES4 Hairy and enhancer of split 4 (Drosophila) 1p36.33 924,207..925,333* ** HES gene family [26,27]
AGRN Agrin 1p36.33 945,366..981,355 Agrn CMS (AR) reduced NMJ [29]
SCNN1D sodium channel, nonvoltage-gated 1, delta 1p36.33 1,207,439..1,217,272 ** highly expressed in
pyramidal neurons
[30]
DVL1 dishevelled, dsh homolog 1 (Drosophila) 1p36.33 1,260,521..1,274,358* Dvl1 SJS (AR), CMT2A (AR) abnormal social interactions [31,32]
MXRA8 matrix-remodelling associated 8 1p36.33 1,277,934..1,283,778* Mxra8 glia limitans/BBB [33]
VWA1 von Willebrand factor A domain
containing 1
1p36.33 1,360,772..1,366,009 Vwa1 peripheral nerve defects ECM protein [34]
MIB2 Mindbomb homolog 2 (Drosophila) 1p36.33 1,540,747..1,555,848 Mib2 exencephaly ubiquitin ligase for
Notch ligands
[35]
MMP23B matrix metallopeptidase 23B 1p36.33 1,557,423..1,559,893 Mmp23 cranial suture closure*** [36]
GNB1 guanine nucleotide binding protein
(G protein), beta polypeptide 1
1p36.33 1,716,725..1,822,526* Gnb1 micrencephaly, NTDs One of three beta
subunits of G proteins
[37]
GABRD GABA A receptor, delta 1p36.33 1,940,703..1,952,050 Gabrd epilepsy pro-epileptic [38]
SKI v-ski sarcoma viral oncogene homolog
(avian)




PEX10 peroxisomal biogenesis factor 10 1p36.32 2,326,101..2,333,870* Pex10 ALD (AR), ZS (AR) [41]
PLCH2 phospholipase C, eta 2 1p36.32 2,397,614..2,426,824 Plch2 Mental retardation neuron-specific isozyme [42]
HES5 Hairy and enhancer of split 5 (Drosophila) 1p36.32 2,450,044..2,451,544* Hes5 premature neuronal differentiation synergistic with Hes1, Hes3 [26,27]
TPRG1L tumor protein p63 regulated 1-like 1p36.32 3,531,416..3,536,555 Tprg1l presynaptic protein [43]
TP73 tumor protein p73 1p36.32 3,558,989..3,639,716 Trp73 Hippocampal, neocortical defects apoptosis [44,45]
KCNAB2 potassium voltage-gated channel,
shaker-related subfamily, beta member 2
1p36.31 6,008,967..6,083,110 Kcnab2 Defects of learning and memory [46]
CHD5 chromodomain helicase DNA binding
protein 5
1p36.31 6,084,440..6,162,770* Chd5 brain development, tumor
suppressor gene
[47]
HES3 Hairy and enhancer of split 3 (Drosophila) 1p36.31 6,226,849..6,228,225 Hes3 premature differentiation with Hes1, Hes5 [26,27]
ACOT7 acyl-CoA thioesterase 7 1p36.31 6,246,919..6,376,413* Acot7 MTLE [48]
HES2 Hairy and enhancer of split 2 (Drosophila) 1p36.31 6,397,883..6,402,566* Hes2 expressed in developing
nervous system
[26,27]
ESPN Espin 1p36.31 6,407,435..6,443,591 Espn congenital hearing loss (AR, AD) jerker deafness actin bundling [49]
PLEKG5 pleckstrin homology domain containing,
family G (with RhoGef domain) member 5
1p36.31 6,448,739..6,502,656* Plekhg lower motor neuron disease (AR) activates NF kappa B [50]
AD autosomal dominant, ALD adrenoleukodystrophy, AR autosomal recessive, BBB blood–brain barrier, CMS congenital myasthenic syndrome, CMT2Ac Charcot-Marie-Tooth disease type 2A, ECM extracellular matrix,
GABA gamma-aminobutyric acid, MTLE mesial temporal lobe epilepsy, NMJ neuromuscular junction, NTD neural tube defect, PHPV persistent hyperplastic primary vitreous, SJS Schwartz-Jampel syndrome, ZS Zellweger
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http://www.actaneurocomms.org/content/1/1/45PMG types may occur together in the same brain, and
(despite their different morphologies) all seem to ex-
hibit similar relative positions of layer-specific neurons
[54]. Also, on neuroimaging, PMG may be difficult to
distinguish from other MCDs, such as pachygyria and
“cobblestone” malformations involving breaches in the
pial surface of the brain, which can also occur together
with PMG in the same brain [55]. Recently, it was pro-
posed that fusion of the molecular layer is a defining
feature of PMG [54]. By this criterion, cortical dysgen-
esis in the present case did not qualify as PMG, since
little to no fusion of the molecular layer could be
discerned (Figure 3). On the other hand, this is the
only case of monosomy 1p36 with histopathological
studies reported so far, and it is possible that authentic
PMG with definite molecular layer fusion might occur in
other cases; dysgenesis in the present case might represent
a mild form of PMG. Alternatively, monosomy 1p36 may
exhibit a unique form of “PMG-like” cortical dysgenesis,
always lacking fusion of the molecular layer. Similarly to
classic PMG [54], cortical dysgenesis in the present case
showed no overall change in the relative positions of
layer-specific neuron types (Figure 3H-K).
Heterotopia in monosomy 1p36
Subcortical heterotopia are caused by defective cell migra-
tion from the fetal ventricular zone to the cortical plate,
and can appear as scattered neurons, laminar bands, or
PNH [52,56]. The first report of PNH in monosomy 1p36
appeared in 2006 [15]. In that case, multiple PNH were
identified in the anterior portion of the left lateral ventricle.
Subsequent reports have described multiple PNH bilaterally
[9], and one PNH in the left lateral ventricle [18] of mono-
somy 1p36 patients. In the present case, multiple PNH
were found in the temporal and occipital horns bilaterally
(Figure. 1, 2 and 3). Thus, so far, there appears to be no
consistent pattern in the distribution of PNH in monosomy
1p36, in contrast to some other forms of PNH, such as
classic bilateral PNH linked to the FLNA gene on chromo-
some Xq28 [52].
Interestingly, laminar-like patterns are sometimes ob-
served in PNH. In the present case, infragranular neurons
(N52+ large pyramids) were located at the center of a
nodule, and supragranular neurons (CR+) at the periphery
(Figure 3M). Previous studies of PNH have reported dis-
parate findings. One group reported that PNH contained
predominantly supragranular neuron types, with very few
infragranular-type neurons [57]. Another group found that
PNH contained infragranular neurons at the periphery of
nodules, with likely supragranular neurons occupying the
center of nodules [58]. Altogether, the available data sug-
gest that PNH may have variable composition, and may
perhaps differ according to the genetic or other etiology of
the malformation.Hippocampal malrotation in monosomy 1p36
Neuroimaging studies suggest that hippocampal malrotation
occurs relatively frequently in association with other MCDs
(22-56%), in seizure disorders (up to 43%), and possibly in
otherwise healthy controls (0-10%) [59-64]. Furthermore,
hippocampal malrotation is the most common abnormality
of the hippocampus associated with febrile status epilepticus
in children [64]. However, the overall significance of the
aforementioned studies has been clouded by the use of dif-
ferent criteria to define hippocampal malrotation, and by a
lack of correlations with histopathology to directly ascertain
the direction and degree of malrotation, as well as any asso-
ciated changes in the organization of hippocampal fields or
subregions. In the present case, hippocampal malrotation
(Figure 4) was associated with seizures. Furthermore,
the morphology suggested an abnormal persistence of fetal
configuration. During normal development, the ventricu-
lar surface of the subiculum comes into contact with the
ventricular surface of the parahippocampal gyrus between
17–20 weeks of gestation [65], and these apposed surfaces
fuse by the end of gestation [66] to form, in the mature
brain, a solid core of white matter between the subiculum,
entorhinal, and transentorhinal areas. Thus, the patho-
genic mechanisms underlying hippocampal malrotation
in this case may have included decreased hippocampal
growth, increased intraventricular pressure, or defective
fusion at the ventricular surfaces.
Deleted genes and possible links to brain malformations
Like other subchromosomal deletion syndromes, mono-
somy 1p36 exhibits considerable phenotypic heterogeneity
that may be attributed to multiple variables such as deletion
size, genetic background, and intrauterine environment.
Notably, the PMG-like cortical dysgenesis in monosomy
1p36 shows incomplete penetrance (~33%) [10] and vari-
able distribution in the cerebral hemispheres and lobes
[10,12-14,18,19]. Likewise, PNH seems to be variable in
monosomy 1p36 [9,15,18]. Whereas the 1p36 region
contains many genes that have been implicated in brain
development or function (Table 1), some phenotypes
presumably result from a combination of gene deficiencies.
For these reasons, at present, it is impossible to definitively
identify which gene deletions cause brain and spinal
malformations in monosomy 1p36. However, reasonable
candidate genes can be proposed on the basis of their
previously defined functions in neurodevelopment, espe-
cially where critical regions have been defined. The brain
phenotypes that seem most likely to have a genetic basis
in the present case are micrencephaly, PMG-like cortical
dysgenesis, and PNH. (As discussed above, hippocampal
malrotation may have been secondary to ventriculomegaly
and decreased overall brain growth).
Micrencephaly is a common finding in monosomy 1p36,
affecting ~61% of patients [3], and was severe in the present
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http://www.actaneurocomms.org/content/1/1/45case. Several important genes that regulate brain size, and
neuronal and glial differentiation, were deleted in this
patient: these included four HES genes (HES2, HES3, HES4,
and HES5), and GNB1. HES (hairy and enhancer of split)
genes are basic helix-loop-helix transcriptional repressors
that mediate the highly conserved Notch signaling pathway,
which, in the nervous system, controls cellular fate choices
between neural stem cell (NSC) maintenance and differ-
entiation of neurons and glia [26,27]. In mice, multiple
Hes genes function in a redundant, gene dose-dependent
manner to mediate canonical Notch signaling. Mice lacking
multiple Hes genes or related effectors undergo accelerated
embryonic neuronal differentiation causing a premature
and transient excess of neurogenesis, followed by NSC
depletion and premature cessation of neurogenesis [27,67].
GNB1 (guanine nucleotide binding protein [G protein], beta
polypeptide 1) encodes a G protein β subunit, one of five
Gβ genes in the mouse and human genomes [37]. Gnb1 de-
ficient mice die prematurely in the embryonic or neonatal
period with neural tube closure defects and micrencephaly
[37]. The concurrent loss of one GNB1 allele and four
HES alleles has never been modeled in mice, but would
presumably be likely to cause micrencephaly.
The penetrance of PMG-like cortical dysgenesis in
monosomy 1p36 has been estimated at ~33%, and the
phenotype appears to be linked to a putative critical re-
gion between 1.0 Mb and 4.8 Mb from the 1p telomere
[10]. This critical region, which was entirely deleted in
the present case, includes several genes that might con-
tribute to the PMG-like phenotype. One such candidate
is TP73 (tumor protein p73), which encodes a member
of the p53 family of transcription factors. In mice,
Trp73 (the TP73 ortholog) is required for brain develop-
ment. Trp73−/− mice show congenital hydrocephalus, hip-
pocampal dysgenesis, absence of the hippocampal sulcus
(a folding defect), decreased expression of reelin and
calretinin (markers of Cajal-Retzius neurons) in the
cortical marginal zone and hippocampal molecular layer,
frontal cortex hypoplasia, occipital cortex dyslamination,
ventralized cortical patterning with expanded entorhinal-
like cortex, increased cortical apoptosis, and probably aber-
rant connections [44,45]. Indeed, it was suggested [44] that
“Extrapolation of the [Trp73−/−] mouse brain defect on the
human brain would predict a substantial reduction of
primary visual cortex and occipitotemporal association
areas, a damage that, combined with the entorhinal malfor-
mation, would lead to severe cognitive disabilities and men-
tal retardation.” Some defects in Trp73−/− mice, such as the
expanded entorhinal-like cortex, seemed to show parallels
in the present case of monosomy 1p36 (Figures 3 and 4).
However, PMG–like festooning of the supragranular
layers was not observed in Trp73−/− mice. Interestingly,
human TP73 is expressed monoallelically and is probably
imprinted [68]. This fact raises the intriguing possibilitythat monosomy 1p36 may be associated with either
complete loss or complete preservation of TP73 expression,
depending on whether the transcriptionally active parental
allele was deleted. If TP73 is imprinted and deficiency
of TP73 causes a brain malformation (e.g., entorhinal
expansion, PMG-like dysgenesis, or PNH), then such
phenotypes may be correlated with deletion of a specific
parental allele in monosomy 1p36. On the other hand,TP73
allele switching has been documented in some circum-
stances [68], and might provide a mechanism to counteract
the effects of deleting an active TP73 allele.
Another leading candidate gene in the putative crit-
ical region for PMG-like cortical dysgenesis is PEX10
(peroxisomal biogenesis factor 10), which encodes a peroxi-
somal RING finger ubiquitin ligase required for peroxisome
biogenesis [69]. Loss-of-function mutations in PEX10
are one cause of Zellweger syndrome [69,70], a severe
neurological disorder characterized by brain findings
of centrosylvian PMG, medial pachygyria, subcortical
heterotopias, and simplified inferior olivary nuclei [41].
However, Zellweger syndrome is a recessive disorder,
and deletion of one PEX10 allele would not account for
brain malformations on its own. Nor was there any history
of peroxisomal disorders in the patient’s family.
Reports of PNH in monosomy 1p36 are too few to esti-
mate prevalence or define a critical region, but cases so far
suggest limited expressivity with relatively few, small PNH.
Usually categorized as a cell migration disorder, PNH may
arise from disruptions of cytoskeletal proteins, vesicle
trafficking, impaired cell adhesion, ependymal defects, or
damage to radial glia [52,57,71]. Among genes deleted in
the present case, MXRA8 (matrix-remodelling associated 8)
encodes an immunoglobulin superfamily cell adhesion
molecule that, in adults, is localized to astrocyte endfeet
that form the glia limitans and blood–brain barrier [33,72].
Although the developmental functions of MXRA8 are
unknown (since no gene deletion studies have been
reported so far), one could speculate that it regulates cell
migration or radial glia morphology. Another speculative
candidate for contributing to PNH in monosomy 1p36 is
CHD5 (chromodomain helicase DNA binding protein 5),
which encodes one component of a chromatin remodeling
complex that is preferentially expressed in the nervous
system [73]. In primary cultured rat neurons, shRNA-
mediated knockdown of Chd5 caused downregulation
of some neuronal genes (such as Fmr1, Dlx1, and Nefm)
and upregulation of others (such as L1cam, Gabrd,
and Ampd3) [47]. Some of these changes, such as the
upregulation of L1cam (which encodes an immuno-
globulin superfamily cell adhesion molecule), might
hypothetically interfere with cell migration and cause
heterotopia. However, the developmental functions of
Chd5 have not been studied in knockout mice and
currently remain unknown.
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been implicated in nervous system function and probably
contribute to developmental delay, epilepsy, and related
neuropsychiatric problems in monosomy 1p36 (Table 1;
Additional file 1). However, genes that are expressed only
in mature postmitotic neurons are less likely to be involved
in the pathogenesis of malformations, and more likely
to contribute to abnormalities of neuronal plasticity or
function. Overall, in most cases of monosomy 1p36,
neurological problems reflect perturbations of both de-
velopmental and mature brain functions.
Conclusions
Our findings provide the first neuropathological evidence
that multiple malformations of brain and spinal develop-
ment occur in monosomy 1p36. The unique morphology
of PMG-like cortical dysgenesis in the present case suggests
that this lesion, in which fusion of the molecular layer was
not evident (Figure 3), differs from classic PMG, in which
fusion of the molecular layer is a defining feature [54].
More generally, our findings suggest that some types of
PMG may exhibit unique morphologic features associated
with different genetic and non-genetic etiologies. Finally,
our analysis of the deleted chromosome region in this
patient allowed us to not only identify candidate genes
for malformations, but also propose a novel mechanism
of phenotypic diversity in monosomy 1p36, namely the
possibility that, due to imprinting, the penetrance of
TP73-dependent phenotypes may be linked to deletion
of a specific parental allele.
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